Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
Regeneron’s High-Dose Aflibercept Receives FDA Approval
Regeneron has received FDA approval for Eylea HD (aflibercept 8 mg) in a significant development anticipated to substantially extend dosing intervals for patients with retinal diseases such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).…
Tenpoint Therapeutics Launches with $70M Financing
Tenpoint Therapeutics, a biotechnology company focused on vision-restoring engineered cell-based therapeutics and in vivo reprogramming for degenerative ocular diseases, has announced its launch with a $70 million Series A financing. The funding will be used to develop the company’s regenerative…
2023 Recap: Top 10 Contact Lenses and Technologies
In the ever-evolving landscape of ophthalmology, 2023 has proven to be a year of groundbreaking advancements in contact lens technology. From lenses that adapt to UV and temperature changes to intelligent lenses capable of diagnosing and treating glaucoma, the top…
Glaucoma Eye Drops List You Need for IOP Management
Glaucoma, a group of eye conditions that damage the optic nerve, is often linked to an increase in intraocular pressure (IOP). Managing IOP is crucial in glaucoma treatment to prevent vision loss. Eye drops play a vital role in this…
Rapid Eye Disease Detection: Mobile App’s Power
Two students on the Master’s Degree in Bioinformatics and Biostatistics at the Universitat Oberta de Catalunya (UOC) have successfully developed a mobile app capable of detecting glaucoma, diabetic retinopathy, and cataracts within a matter of seconds. These three conditions are…
History of Cataract Surgery | OBN
A cataract is a pathologic condition in which the eye’s lens opacifies, resulting in changes to vision that can range from color changes and blurriness to halos around lights and, in the worst case scenario, blindness. A senile cataract, in…
Carl Zeiss Meditec to Acquire D.O.R.C.
Carl Zeiss Meditec AG announced that they have entered into an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from Eurazeo SE, based in Paris, France. The deal is worth €985 million (nearly…
LVPEI and CORE Form Strategic Partnership
In a significant development in the field of eye care and vision science, the L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have established a strategic partnership. This alliance,…
RevOpsis Raises $16.5M for Wet AMD Treatment
RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing a total of $16.5 million. This funding is set to advance the development and commercialization of treatments for chronic multifactorial diseases through the company’s innovative, fully…
10 Organizations Making a Difference in Eye Health
In the vast and complex world of healthcare, eye health often doesn’t receive as much attention as it should, despite being crucial to our quality of life. Vision problems and blindness significantly affect millions of people globally, hindering education, employment,…